The study established a mouse model of checkpoint blockade-associated autoimmunity by injection of anti-CTLA4 antibodies or isotype controls to test the response of mice to oral dextran sodium sulfate (DSS) and showed that disease was particularly severe in mice receiving 3% DSS and in mice receiving anti-CTLA4 antibodies. This evidence concerns the gene CTLA4 and Autoimmunity.